Development of a Pharmacogenomic Panel for Early Detection of Chemotherapy- and Immunotherapy-Induced Cardiotoxicity.
Development of a Pharmacogenomic Panel for Early Detection of Chemotherapy- and Immunotherapy-Induced Cardiotoxicity.
Recruiting · NCT07663357 · Registry updated 2026-06-23Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Development of a Pharmacogenomic Panel for Early Detection of Chemotherapy- and Immunotherapy-Induced Cardiotoxicity. | Cardiotoxicity, Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Pathologic Processes, Pathological Conditions, Signs and Symptoms, cardiovascular disorder, heart disorder, injury, neoplasm, radiation injury | Recruiting | Not stated | 2026-06-23 | NCT07663357 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Beneficência Portuguesa de São Paulo | 10 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Complexo Hospitar HUOC/PROCAPE | Recife | Brazil | 1 |
| FAMERP - Faculdade de Medicina de São José do Rio Preto | São José do Rio Preto | Brazil | 1 |
| Hospital Beneficente UNIMAR | Marília | Brazil | 1 |
| Hospital BP - A Beneficência Portuguesa de São Paulo | São Paulo | Brazil | 1 |
| Instituto do Câncer do Ceará | Fortaleza | Brazil | 1 |
| Universidade Federal de Santa Catarina | Florianópolis | Brazil | 2 |